Latest filing published 16 Oct 2020 for Silence Therapeutics plc, €5,530.
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Alistair Gray: trading record in brief
This profile gathers the share dealings of Alistair Gray in Silence Therapeutics plc. We count 4 filings; the first trade dates from 2 August 2017 and the latest from 14 October 2020.
Purchases make up the whole of the open-market record (3 purchases, €18k). Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. The rest of the record consists of 1 option exercise. Since January 2020: 1 purchase and no sales on the market.
The median purchase comes to €5,572.
On 16 October 2020 came the latest disclosure, an open-market purchase for €5,530 in Silence Therapeutics plc. Filings reach the RNS (LSE) feed a median of 2 days after the trade. Under the UK Market Abuse Regulation, managers have three business days to notify their trades. Every figure here comes from the filings published by RNS (LSE) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Alistair Gray
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 1,258 shares@ £3.9686London Stock Exchange, AIMISIN GB00B9GTXM62FCA-NSM:3751051Canonical exit: 12 Jan 2021 (T+90)
- 3,171 shares@ £1.8998.7% of flowLondon Stock Exchange, AIMISIN GB00B9GTXM62FCA-NSM:LSE20191003154008_14253413_20200326185156039_32916Canonical exit: 31 Dec 2019 (T+90)
- 1,626 shares@ £0.051.3% of flowOutside a trading venueISIN GB00B9GTXM62FCA-NSM:LSE20191001180637_14249968_20200326185156367_36210
- 3,848 shares@ £1.297545.0% of flowLondon Stock Exchange, AIMISIN GB00B9GTXM62FCA-NSM:LSE20170803070008_13317715_20200330131542791_2198Canonical exit: 31 Oct 2017 (T+90)
4 of 4 declarations